Infectious Disease · New Smyrna Beach, FL
NPI
1356348593
Since 2005
Specialty
Infectious Disease
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
410 Palmetto St
New Smyrna Beach, FL, 32168
Phone (386) 410-4981
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,272 services
Medicare patients, 2024
523
Average age 76
Drug cost, 2024
$4.0M
3,814 prescriptions
Company payments, 2025
$2,398
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reba K Isaac was code 99214 (office e&m - established), 463 times for 196 patients. In total Reba K Isaac billed 1,272 services in 11 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 463 | 196 | $92.65 | $43K |
| 99232 Hospital E&M - Subsequent | Facility | 313 | 187 | $60.76 | $19K |
| 99222 Hospital E&M - Initial | Facility | 190 | 172 | $102.09 | $19K |
| 99213 Office E&M - Established | Office | 151 | 107 | $58.63 | $8,853 |
| 99204 Office E&M - New | Office | 111 | 111 | $126.40 | $14K |
| 99223 Hospital E&M - Initial | Facility | 26 | 22 | $131.16 | $3,410 |
By year: 2022 $98K for 1,231 services; 2023 $115K for 1,390 services; 2024 $108K for 1,272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reba K Isaac prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 216 prescriptions and refills. In total Reba K Isaac wrote 3,814 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 216 | 224 | 25 | $654K |
| Azithromycin Generic | 175 | 215 | 35 | $5,488 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 155 | 155 | 21 | $609K |
| Fluconazole Generic | 154 | 161 | 86 | $2,473 |
| Doxycycline Hyclate Generic | 149 | 187 | 67 | $2,814 |
| Juluca Dolutegravir/Rilpivirine | 130 | 132 | 13 | $461K |
| Cefuroxime Cefuroxime Axetil | 120 | 130 | 75 | $3,442 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 120 | 142 | 35 | $994 |
| Ethambutol Hcl Generic | 120 | 164 | 30 | $6,650 |
| Fosfomycin Tromethamine Generic | 116 | 119 | 34 | $21K |
| Minocycline Hcl Generic | 108 | 152 | 30 | $2,959 |
| Cephalexin Generic | 103 | 130 | 39 | $1,729 |
| Trimethoprim Generic | 100 | 127 | 29 | $3,822 |
| Nystatin Generic | 84 | 85 | 48 | $1,255 |
| Cefdinir Generic | 79 | 79 | 58 | $1,611 |
Brand drugs: - claims; generic drugs: 2,815 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reba K Isaac $2,398 ($2,398 in general payments such as food, travel and fees) from 16 companies. The largest payer was ViiV Healthcare Company with $480.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 26 | $480 |
| Gilead Sciences, Inc. GILD | 21 | $472 |
| Merck Sharp & Dohme LLC MRK | 9 | $226 |
| Theratechnologies Inc. THTX | 6 | $216 |
| Abbvie Inc. ABBV | 10 | $178 |
| Baxter Healthcare BAX | 4 | $158 |
| Tetraphase Pharmaceuticals, Inc. | 7 | $153 |
| Insmed, Inc. INSM | 7 | $139 |
| EMD Serono, Inc. MRK.DE | 4 | $76.64 |
| La Jolla Pharmaceutical Company | 4 | $74.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.